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Background: Heart failure (HF) is a debilitating condition that affects millions of people worldwide. One means
of treating HF is cardiac resynchronization therapy (CRT). Recently, several studies have examined the use of
echocardiography (ECHO) in the optimization of left ventricular (LV) lead placement to increase the response to
CRT. The objective of this study was to synthesize the available data on the comparative efficacy of
image-guided and standard CRT.
Methods: We searched the PubMed, Cochrane, Embase, and ISI Web of Knowledge databases through April 2014
with the following combinations of search terms: left ventricular lead placement, cardiac resynchronization
therapy, image-guided, and echocardiography-guided. Studies meeting all of the inclusion criteria and none of
the exclusion criteria were eligible for inclusion. The primary outcome measures were CRT response rate, change
in LV ejection fraction (LVEF), and change in LV end systolic volume (LVESV). Secondary outcomes included the
rates of all-cause mortality and HF-related hospitalization.
Results: Our search identified 103 articles, 3 of which were included in the analysis. In total, 270 patients were
randomized to the image-guided CRT and 241, to the standard CRT. The pooled estimates showed a significant
benefit for image-guided CRT (CRT response: OR, 2.098, 95 % CI, 1.432–3.072; LVEF: difference in means, 3.457,
95 % CI, 1.910–5.005; LVESV: difference in means, −20.36, 95 % CI, −27.819 – −12.902).
Conclusions: Image-guided CRT produced significantly better clinical outcomes than the standard CRT.
Additional trials are warranted to validate the use of imaging in the prospective optimization of CRT.
Keywords: Cardiac resynchronization therapy, Heart failure, Echocardiography, Image-guided, Echocardiography
guidedBackground
Heart failure (HF) is a debilitating and highly prevalent
condition. Recent estimates of the prevalence of heart
failure in Asia range from almost 1 % to greater than
6.5 %, [1, 2], while it ranges from 2 % to 3 % in the United
States [3], and in two of the representative European pop-
ulations [4, 5]. The World Health Organization’s most re-
cent report on disease burden indicated that almost 6
million people were diagnosed with HF in a single year
[6]. Many of these were elderly, and multiple studies have* Correspondence: junjunjun0527@hotmail.com
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unless otherwise stated.demonstrated that the prevalence of HF is greater in older
individuals [3, 7]. The ageing of the world’s population
translates to an even greater burden in the coming de-
cades [1, 8–10]. Moreover, the increasing prevalence of
diabetes, a risk factor and co-morbidity of HF, further
worsens the clinical outcomes [11–22]. The management
of HF may need to focus not only on prevention, but also
on increasing the treatment success: one recent study of
approximately 5 million people in Scotland found that
from 1986 to 2003, the median survival after first
hospitalization only increased to 1.79 years for women
and 2.34 years for men (up from 1.32 and 1.33 years,
respectively) [23].is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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chrony are common abnormalities. One treatment op-
tion for these patients is cardiac resynchronization
therapy (CRT). Since its implementation over 20 years
ago, CRT has been proven to improve the outcomes of
those with HF [24–28]. However, almost one third of
patients who receive CRT do not benefit, giving rise to
the concept of non-response [29, 30]. Although non-
response is an ongoing and controversial issue in CRT
[24, 31], studies conducted over 10 years ago revealed
that optimizing the pacing site can improve the out-
comes and response [32–34].
The use of echocardiography (ECHO) is one method
by which lead placement may be optimized. Speckle
tracking ECHO (STE), which traces patterns of acoustic
signals (i.e., speckles) over time, is a validated device to
measure myocardial strain. By measuring strain and
strain rate, STE can detect regions of scarred myocar-
dium as well as crucial features of dyssynchrony [35].
Vector velocity imaging ECHO (ECHO-VVI) is a vari-
ation on STE that also tracks the movement of the user-
defined endocardial border [36]. Several groups have
used STE or ECHO-VVI not only to define the systolic
volume and the latest site of activation, but also to show
an association between these factors, concordant lead
placement, and CRT response [37–39]. Given the suc-
cess of these studies, research is now focused on the use
of ECHO techniques such as, STE and VVI to prospect-
ively guide lead placement to maximize the effects of
CRT. However, a quantitative synthesis of the available
data has not yet been published. Accordingly, the objective
of the current study was to determine the comparative ef-
ficacy and safety of image-guided and conventional CRT.
Methods
Search strategy
The methods used in this review and meta-analysis ad-
here to the current best practices for conducting system-
atic reviews of the literature. We searched the PubMed,
Cochrane, Embase, and ISI Web of Knowledge databases
through April 28, 2014 by using the following combina-
tions of search terms: left ventricular lead placement,
cardiac resynchronization therapy, imaging-guided, and
echocardiographically guided. Our search strategy in
PubMed included the following terms: left ventricular
lead placement AND cardiac resynchronization therapy
AND (imaging OR echocardiographically guided). Our
search filters were: abstract available, English language,
and human species.
After the removal of duplicate citations, we identified
relevant studies using a 2-step search process. In the
first step, we screened the title and abstracts of all cita-
tions identified in the search against the inclusion and
exclusion criteria (see below). In the second step, weretrieved the full texts of the remaining articles. Studies
meeting all of the inclusion criteria and none of the ex-
clusion criteria were included in the analysis.
Selection of studies
The inclusion criteria for this meta-analysis were as fol-
lows: 1- The study was a randomized controlled trial
(RCT) or a 2-arm prospective study; 2- The study enrolled
patients with heart failure who received a CRT pacemaker
(CRT-P) or a CRT implantable cardioverter defibrillator
(CRT-D) device. A study was excluded for the following
reasons: 1- It was a retrospective or cohort study, letter,
comment, editorial, or case report; 2- The enrolled pa-
tients received other interventions besides those men-
tioned above.
Data extraction
The following data were extracted from the included
studies: first author, year of publication, study design,
trial name if applicable, type of intervention, follow-up
time, number of patients enrolled, proportion of male
patients, New York Heart Association (NYHA) grade of
the enrolled patients, width of the QRS, baseline and
post-treatment left ventricular ejection fraction (LVEF),
baseline and post-treatment left ventricular end-systolic
volume (LVESV), concordance of the LV lead to the
latest site of activation, odds ratio (OR) for the CRT
response, and the rates of CRT response, all-cause mor-
tality, and HF-related hospitalization. Two independent
reviewers extracted the data from the eligible studies,
and any disagreements were resolved by consulting a
third reviewer.
Outcome measures
The primary outcome measures of this analysis were CRT
response rate, change in LVEF, and change in LVESV. All
3 included studies defined the CRT response, differently.
Khan et al. defined response as LV reverse remodeling
(≥15 % decrease in LVESV) at 6 months, Saba et al. as LV
reverse remodeling or a ≥5 % absolute increase in LVEF,
both with no primary endpoint, and Bai et al. required 2
of 3 criteria: LV reverse remodeling, a ≥20 % relative in-
crease in LVEF, or a 1-class decrease in NYHA functional
status.
Secondary outcomes included the rates of all-cause mor-
tality and HF-related hospitalization.
Quality assessment
The quality of the included studies was assessed with
the Cochrane Risk of Bias tool, a component of Review
Manager 5.1. The assessment is categorized into six
domains—random sequence generation (selection bias),
allocation concealment (selection bias), blinding of pa-
tients and personnel (detection bias), blinding of
Fig. 1 A flow diagram of the process for study selection
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data (attrition bias), and selective reporting risk (reporting
bias)—that are described in Chapter 8 of the Cochrane
Handbook for Systematic Reviews Interventions [40].
Statistical analysis
The OR and corresponding 95 % confidence intervals (CI)
of the CRT response, difference in means of change in
LVEF, and the difference in means of change in LVESV
were used to evaluate the efficacy of image-guided CRT
compared to standard CRT. For the OR of the CRT re-
sponse, an OR > 1, indicates that the image-guided CRT
group tended to have a higher response rate than the
standard CRT group, while an OR < 1, indicates that the
image-guided CRT group tended to have a lower response
rate than the standard CRT group, and an OR = 1, indi-
cates that the response rates were similar for both the
groups. For the difference in means of LVEF, an OR > 0,
indicates that image-guided CRT lead to a greater change
(i.e., from pre- to post-treatment) in outcome than did
standard CRT, an OR < 0, indicates that image-guided
CRT lead to a lesser change in the outcome than the
standard CRT, while an OR = 0, indicates that the two pro-
cedures had similar effects on the change in outcome. For
the difference in means of LVESF, an OR > 0, indicates that
image-guided CRT lead to a lesser change in the outcome
than the standard CRT, an OR < 0, indicates that image-
guided CRT lead to a greater change in outcome than did
the standard CRT, and an OR = 0 indicates that the 2 pro-
cedures affected the change in outcome to a similar ex-
tent. Either a Cochran Q statistic of P < 0.1 or an I2
statistic > 50 % was considered as obvious heterogeneity
among studies. When heterogeneity was detected, a
random-effects model was preferred; otherwise, a fixed-
effects model was considered. Sensitivity analysis was per-
formed by using the leave-one-out approach. A funnel plot
and Egger’s test were not used because publication bias
cannot be analyzed accurately with 5 studies or less [41].
A two sided P value < 0.05 was considered statistically sig-
nificant. All statistical analyses were performed with Com-
prehensive Meta-Analysis statistical software, version 2.0
(Biostat, Englewood, NJ, USA).
Results
Study selection
A flow chart for study selection is shown in Fig. 1. Of
the 103 studies identified in the initial search, 100 were
excluded after a full text review, due to the lack of rele-
vance. The remaining 3 studies met all of the inclusion
criteria and were included in the meta-analysis.
Study characteristics
A summary of the characteristics of the trials and pa-
tients is presented in Table 1. The included studiesconsisted of 2 RCTs, by Khan et al. [42] and Saba et al.
[43], conducted in the United Kingdom and United
States, respectively, and 1 prospective cohort study by
Bai et al. [44] conducted in the United States and Italy.
The studies by Khan et al. and Saba et al. assessed
speckle-tracking ECHO, while Bai et al. assessed ECHO
coupled with VVI. The standard CRT used empiric
placement of LV leads and was facilitated only by coron-
ary venography, with a preference for a lateral, posterior,
or posterolateral region as the implantation site. In total,
511 patients were enrolled, with 270 randomized to the
image-guided group and 241 to the standard CRT group.
Follow-up times for the studies ranged from 6 months
to just over 3 years. The mean or median age of enrolled
patients ranged from 61 to 72 years, with 60 % to 80 %
of the patients being men. The majority of patients were
classified as New York Heart Association (NYHA) func-
tional class III or IV, although Saba and colleagues en-
rolled a small percentage of patients (approximately
12 %) belonging to class II. The average left ventricular
ejection fraction (LVEF) and QRS width were similar
among the 3 studies, ranging from 23 % to 26 % and 153
to 162 milliseconds, respectively.
Outcomes of interest
Data for the outcomes of each study are summarized in
Table 2. While only Khan et al. and Bai et al., reported
the OR for CRT response, all 3 publications reported
data for the percentage of subjects who responded to
CRT and for the other two primary outcomes of change
from the baseline in LVEF and LVESV. Just one study,
that of Saba et al., reported group-specific data for the
secondary outcomes of the rates of all-cause mortality
and HF-related hospitalization.
CRT response
We generated a Forest plot (Fig. 2A) to illustrate the in-
dividual and pooled ORs for CRT response. All 3 groups

















RCT (STARTER) Image-guided 1.8 ± 1.3 yrs 110 66 ± 11 70 % II/III/IV: 16/64/20a 26 ± 6 157 ± 27
Standardb 77 67 ± 13 78 % II/III/IV: 8/71/21a 26 ± 7 162 ± 27
Khan (2012)
[42]
RCT (TARGET) Image-guided 2 yrs 110 72 (65–76) 77 % III/IV: 95/15c 23 ± 6 157 (148–170)
Standardb 110 72 (64–80) 80 % III/IV: 93/17c 23 ± 7 159 (146–170)
Bai (2011)
[44]
Prospective study Image-guided 6 mths 50 66 ± 11 60 % III or IV: 3.10 ± 0.30d 23 ± 7 153 ± 23
Standardb 54 64 ± 9 74 % III or IV: 3.07 ± 0.26d 26 ± 6 155 ± 29
Abbreviations: CRT cardiac resynchronization therapy, NYHA New York Heart Association, LVEF left ventricular ejection fraction, RCT randomized control trials, yrs
years, mths months, no number
Data are presented as mean ± SD or median (inter-quartile range), unless noted otherwise. bStandard procedures means that empiric placement of LV leads was
only facilitated by coronary venography, with a preference for a lateral, posterior, or posterolateral region as an implantation site. adata are presented as
percentage; cdata are presented as counts; ddata are presented as mean ± SD
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were more likely to have a higher CRT response. For the
pooled estimate, the Cochran Q statistic was 0.377 with
p = 0.828 and the I2, was 0. These values indicated a lack
of obvious heterogeneity among the studies; thus, a
fixed-effect model was performed to determine the
pooled OR for CRT. The pooled estimate for the OR of
CRT response also showed that patients in the image-
guided CRT treatment group had a significantly higher
response rate than those who received standard CRT
(OR: 2.098; 95 % CI: 1.432–3.072, p < 0.001). A sensitiv-
ity analysis based on the leave-one-out approach (Fig. 2B)
determined that the pooled OR was robust, because the
ORs determined with each study removed were similar
to that of all 3 studies combined.
Change in LVEF
The individual and combined differences in means for
change in LVEF are illustrated in a Forest plot in Fig. 3A.
Khan et al. and Bai et al. both reported that the change in
LVEF was significantly greater for the image-guided CRT
treatment group than for the standard CRT group. The re-
sults of Saba et al. also favored image-guided CRT, but
lacked statistical significance. As with the outcome of
CRT response, the studies lacked heterogeneity (Cochran
Q = 1.132, p = 0.568; I2 = 0); therefore, a fixed-effects
model was performed. The pooled estimate of the differ-
ence in means of the change in LVEF was 3.457 (95 % CI:
1.910–5.005, p < 0.001), which indicates that patients who
underwent image-guided CRT experienced a significantly
greater improvement in LVEF than did those who under-
went standard CRT. Our sensitivity analysis revealed that
the pooled estimate of the difference in means for all 3
studies was similar to those for each pair (Fig. 3B).
Change in LVESV
The Forest plot in Fig. 4 shows the individual and
pooled difference in means for change in LVESV. All of
the studies found that the improvement in LVESV wasgreater in the image-guided CRT group than in the
standard therapy group; however, the data of Bai et al.
did not reach statistical significance. Because Saba et al. re-
ported change as a relative value, data from this trial were
not included in the meta-analysis. As with the other pri-
mary outcomes, a fixed-effects model was performed, due
to the lack of heterogeneity (Cochran Q = 0.115, p = 0.734;
I2 = 0). The pooled estimate of the difference in means of
the change in LVESV (−20.36, 95 % CI: −27.819 – −12.902,
p < 0.001) showed that the average reduction of LVESV
was greater in the image-guided CRT group than in the
standard CRT group.
Secondary and other outcomes
Reporting of the secondary outcomes of this meta-
analysis—all-cause mortality and HF-related hospitaliza-
tion—varied widely among the included studies. Saba
et al. reported group-specific data for both outcomes,
while Khan et al. reported the data for both outcomes for
all enrolled patients. However, Bai et al. did not report
data for either of the outcomes. The results of Saba and
colleagues indicate that mortality from any cause may be
similar for both the treatments, but use of image-guided
CRT may lead to lesser HF-related hospitalizations.
We also compared data reported by Khan et al. and Saba
et al. for the concordance of LV lead placement to the lat-
est site of activation (Table 2; Bai et al. did not report this
outcome). In both trials, exact or adjacent concordance
was obtained for a greater number of patients in the
image-guided group than in the standard CRT group. Ac-
cordingly, the image-guided CRT group had a lower per-
centage of remote placements, with remote placements
being more than twice as numerous in the standard CRT
group.
Quality assessment
We used the Risk of Bias tool, a component of Cochrane’s
Review Manager, to assess the quality of the included
studies (Table 3). Our analysis revealed different levels of














LVESV (ml), mean ± SD Change from
baseline






Baseline Post treatment Baseline Post treatment Change from baseline
Saba (2013)
[43]
Image-guided Exact/adjacent: NR 50 (57 %) 140 ± 59 NR −30± 29 (%)a 26 ± 6 38 ± 12.8b 12 ± 11 15 (13.6 %) 16 (14.5 %)
30/NR
Exact or adjacent: 85
Remote: 15
Standard Exact/adjacent: 22 (35 %) 144 ± 63 NR −20± 25 (%)a 26 ± 7 35 ± 11.45b 9 ± 10 15 (19.5 %) 21 (27.3 %)
12/NR




Image-guided Exact/adjacent: 1.92 (1.08, 3.39) 72 (70 %) 157 ± 56 111 ± 43 −46± 33 (ml) 23 ± 6 31 ± 9 8 ± 7 22 (10 %) 18 (8 %)
63/26
Exact or adjacent: NR
Remote: 10
Standard Exact/adjacent: 1.0 (reference) 57 (55 %) 154 ± 52 128 ± 50 −26± 23 (ml) 23 ± 7 28 ± 10 5 ± 8
47/29




Image-guided NR 2.68 (1.08-6.65)c 41 (82 %) 172 ± 65 129 ± 65 −43± 65 (ml) 23 ± 7 34 ± 10 11 ± 8.89d NR NR
Standard NR 1.0 (reference) 34 (63 %) 159 ± 74 141 ± 82 −18± 78 (ml) 26 ± 6 32 ± 9 6 ± 7.94d NR NR
Abbreviations: CRT cardiac resynchronization therapy, LV left ventricular, EF ejection fraction, LVESV left ventricular end-systolic volume, ml milliliters, SD standard deviation, NR not reported, HF heart failure
aRepresented as a relative change before and after treatment
bData were estimated according to the reported results of baseline and change from baseline; n = 87 for the image-guided group and n = 62 for the standard group
cWith adjustment for clinical characteristics













Fig. 2 A Forest plot showing the results of a meta-analysis of CRT response rate (A) and the corresponding sensitivity-analysis (B) for the patients
who received image-guided or standard CRT. (A) The pooled estimate favors image-guided CRT. (B) The pooled estimates of all 3 studies and
each pair are similar. Abbreviations: CI, confidence interval; CRT, cardiac resynchronization therapy; Lower limit, lower bound of the 95 % CI; Upper
limit, upper bound of the 95 % CI
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tection bias (see Methods). The publication by Khan et al.
clearly documented the utility of a computer-generated
system and stated that the group assignment used a cen-
tral, fully independent system. Moreover, the patients and
the assessor were blinded, and the process of blinding wasFig. 3 A Forest plot showing the results of a meta-analysis of post-treatment
patients who received image-guided or standard CRT. (A) The pooled estimat
each pair are similar. Abbreviations: CI, confidence interval; CRT, cardiac resync
lower bound of the 95 % CI; Upper limit, upper bound of the 95 % CIclearly stated. Therefore, this trial had a low risk of bias in
these domains. Saba et al. stated that the patients and the
healthcare providers were blinded, but the implanting
physician was not. In addition, these authors presented in-
sufficient information about the stratification methods,
resulting in an unclear risk of bias. The study of Bai et al.change in LVEF (A) and the corresponding sensitivity-analysis (B) for the
e favors image-guided CRT. (B) The pooled estimates of all 3 studies and
hronization therapy; LVEF, left ventricular ejection fraction; Lower limit,
Fig. 4 A Forest plot showing the results of a meta-analysis of post-treatment change in LVESV (in milliliters) for the patients who received
image-guided or standard CRT. The pooled estimate favors image-guided CRT. Abbreviations: CI, confidence interval; CRT, cardiac
resynchronization therapy; LVESV, left ventricular end-systolic volume; Lower limit, lower bound of the 95 % CI; Upper limit, upper bound of
the 95 % CI
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and allocation concealment was not described in the pub-
lished results. However, the authors confirmed that con-
secutive patients were enrolled and that local cardiologists
were blinded to the procedure. In addition, they reported
that the operators performed at least 10 image-guided
CRT implants before including patients, making it unlikely
that bias could occur as a result of non-randomization or
sequential learning. All 3 publications contained informa-
tion on the follow-up time and the methods used to han-
dle missing data, and thus the studies had a low risk of
attrition bias. They also had a low risk of reporting bias, as
data were presented for all of the pre-specified outcomes.
Discussion
In this meta-analysis, we determined the comparative ef-
ficacy of image-guided and standard CRT in patients
with HF. Three studies enrolling approximately 500 pa-
tients were included in the analysis. Although other
meta-analyses have addressed the ability of STE and/or
VVI to predict or identify the determinants of CRT
response, we believe that ours is one of the only analyses
published to date that examines the ability of these pro-
cedures to prospectively optimize lead placement. Ac-
cordingly, this work provides an important update to the
field. The results indicate that image-guided CRT is sig-
nificantly better than the standard CRT in improving the
overall response, LVEF, and LVESV. A better CRT re-
sponse is consistent with better improvement of LVEF
and LVESV in the image-guided group, as compared to












Saba (2013) [43] Y Unclear Y
Khan (2012) [42] Y Y Y
Bai (2011) [44] N N Unclear
Y low risk of bias, N high risk of bias, Unclear insufficient data for judgmentthe need to synthesize data from multiple studies, as
some of the individual data lacked statistical significance.
This analysis also revealed the variation in endpoints re-
ported by RCTs or prospective studies of CRT and leads
us to propose that greater standardization will increase
the benefits of future research. This is especially true for
HF-related hospitalization, as these data could provide
crucial information on the financial burden of HF.
The effect estimates determined by the pooled analysis
were largely concordant with each study’s individual re-
sult. The diverse definitions of the CRT response in the
studies included, may have contributed to the wide
range of response rates (control group: 22 %–57 %,
image-guided group: 41 %–72 %). The data reported for
the change in LVEF, while supporting image-guided
CRT, did not reach statistical significance in one of the
three studies. Our pooled estimate was able to take ad-
vantage of the increased patient number to determine
whether the use of STE or VVI in guiding the LV lead
placement has a significant effect on this clinical out-
come. Similarly, when data for the change in LVESV
were pooled, we found a significant benefit for patients
in the image-guided group.
Although we did not conduct a meta-analysis of data
for the concordance of LV lead position to the site of lat-
est activation, our summarized results support the hy-
pothesis that the superior outcome in patients in the
image-guided CRT group, is in part due to the improved
concordance of lead placement. Both the TARGET and
STARTER trials found that patients whose LV leads were
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were confirmed by 3 recent studies: Kydd et al., analyzed
a subset of patients from the derivation and randomized
groups of the TARGET trial, [45]. They have demon-
strated a superior CRT response and improved survival
by optimal LV lead position at the site of latest mechan-
ical activation, and by avoiding low strain amplitude
(scar). Similar results were reported by Marek et al. in a
subgroup of the STARTER population of patients with-
out left bundle branch block (LBBB) or a QRS duration
between 120 and 149 milliseconds [46], and by Adelstein
et al., where they observed defibrillator therapy-free sur-
vival at 3 years among the patients in STARTER trial
[47]. Though, our present data is not sufficient enough
to perform a meta-analysis of concordant/adjacent vs.
remote LV lead, the aforementioned studies strongly
suggest the favorable impact of image-guided CRT on
long term survival.
Image-guided CRT may also provide superior results
by virtue of its ability to target LV leads to sites that are
remote from regions with low radial strain, a hallmark of
scarred myocardium. The TARGET trial assessed the re-
lationship between sites of scar and lead placement, and
discovered that the lead placement in regions remote
from a scar yields improved outcomes. Sade et al. ad-
dressed the issue of scars in a follow-up to the STARTER
trial [48]. This study evaluated both the effects of lead
placement within the scarred segments and the interaction
between scars and activation. In ischemic patients, LV lead
placement within or adjacent to the scarred segments had
a significantly negative effect on survival when compared
to leads that were remote to the scar. Moreover, the clin-
ical outcomes were better in patients when the lead was
placed at the latest site of activation and remote to a scar,
than in those with a lead placed both within a scar and at
the latest-activation site. As Vernooy et al. recently noted
[49], the current body of research strongly suggests that
the presence of scars near a lead will hinder the response
to CRT. The results from the STARTER and TARGET tri-
als, as well as those from a recent study by Kydd et al.
[50], support this conclusion. However, Vernooy and
colleagues noted the lack of evidence to recommend tar-
geting LV leads during CRT. The work of Sade et al. dem-
onstrated the additive value of this aspect of optimization,
as survival of patients with a lead being both concordant
and remote to the scar was better than a non-concordant
lead being remote to a scar [48]. Taken together, the avail-
able data from the 3 patient populations included in our
analysis indicate that the use of image-guided CRT will
improve outcomes, as it provides superior ability not only
to detect and avoid scar, but also to place leads in a loca-
tion best suited for resynchronization.
The studies included in our meta-analysis showed vari-
ability in both the primary and secondary endpoints. Baiet al. and Khan et al. had a primary endpoint of response,
but the primary endpoint of Saba et al.—all-cause mortal-
ity or HF-related hospitalization—was a secondary out-
come only for Khan et al. Among secondary endpoints,
just Khan et al. and Bai et al. assessed post-procedural
NYHA functional class. The included studies also varied
in the reporting of regression analyses to determine factors
with predictive value: 2 used regression analyses to identify
predictors of outcome; however, the outcomes differed:
Bai et al. reported predictors of CRT response while Khan
et al. identified predictors of LV reverse remodeling. These
differences limit the strength of the present meta-analysis
and prompt us to suggest an increased uniformity in end-
point classification across trials. Likewise, whether the effi-
cacy and effectiveness of image-guided CRT response
observed in this study will hold true irrespective of the
underlying heart failure etiology is not known, as the stud-
ies did not compare the CRT response in patients with
non-ischemic and ischemic heart failure. Nevertheless,
studies elsewhere suggest that, though the improvement
of the left ventricular function and remodeling is greater
in non-ischemic cardiomyopathy patients, there was no
difference in CRT response in terms of reduced mortality
or heart failure hospitalization rate between ischemic and
non-ischemic heart failure patients [51]. An increase in LV
outflow-tract velocity-time-integral and LV ejection fraction
after simultaneous CRT was greater in non-ischemic heart
failure patients. However, interventricular pacing interval
optimization yielded a similar CRT response in both ische-
mic and non-ischemic heart failure patients [52].
This study had several limitations. First, the relatively
small sample size of the three studies that met the eligi-
bility criteria, along with the differences in clinical out-
comes analyzed, is a major limitation of the current
meta-analysis. Although the pooled estimates were ro-
bust in our analysis, similar results from a larger cohort
of patients would further strengthen our conclusions.
However, reports indicate that systematic reviews with
small numbers of included studies will be accurate in
the final point estimates in the long run [53]. Second, we
could not conduct a meta-analysis of clinical outcomes
such as HF-related hospitalization and mortality because
of insufficient data, as mentioned above. Third, we did
not conduct a subgroup analysis of the comparative per-
formance of image-guided and standard CRT to place
leads away from regions of scar.
Conclusion
In conclusion, we have conducted a meta-analysis of the
comparative efficacy of image-guided and standard CRT
in patients with HF. Our results indicate that a strategy
of echocardiographic guidance is associated with im-
proved outcomes compared with a routine strategy. Our
analysis also revealed the need for improved reporting
Jin et al. BMC Cardiovascular Disorders  (2015) 15:36 Page 9 of 10standards regarding outcomes including mortality and
HF-related hospitalization. Given the limited number of
studies included in our analysis, the evidence for the im-
provement of clinical outcomes should be strengthened
with data from additional clinical trials.
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